1 / 4

European Inflammatory Bowel Disease (IBD) Market Market Size, Share and Forecast 2019-2025

European IBD market is estimated to grow significantly at a CAGR of around 5.1% during the forecast period. Europe consists of numerous key economies including the UK, Germany, France, Spain, Italy, and others which register a significant share in the market.

mansi3210
Download Presentation

European Inflammatory Bowel Disease (IBD) Market Market Size, Share and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research European Inflammatory Bowel Disease (IBD) Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our European Inflammatory Bowel Disease (IBD) Market: https://www.omrglobal.com/request-sample/european-ibd-inflammatory-bowel-disease-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

  2. European IBD market is estimated to grow significantly at a CAGR of around 5.1% during the forecast period. Europe consists of numerous key economies including the UK, Germany, France, Spain, Italy, and others which register a significant share in the market. The changing lifestyle and significant share of the population which engages in smoking is also one of the key reasons which are expected to increase the prevalence of IBD in the region. The European Federation of Crohn's & Ulcerative Colitis Associations is one such organization in the region which engages in the monitoring of IBD and conducting clinical studies so as to develop an efficient treatment alternative for IBD. Furthermore, the prevalence of IBD increases with a change in eating patterns and unhealthy eating and smoking practices. It is observed that smoking is one of the key reasons which promotes the prevalence of IBD in the working-age population. The percentage of population smoking in the UK is majorly between the age group of 25-34. Owing to this, the prevalence of IBD is expected to increase, thereby creating opportunities for the growth of the market in the near future. A full Report of European Inflammatory Bowel Disease (IBD) Market is Available at: https://www.omrglobal.com/industry-reports/european-ibd-inflammatory-bowel-disease-market European IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. European IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market is segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti- inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD. Request a Free Sample of our European Inflammatory Bowel Disease (IBD) Market: https://www.omrglobal.com/request-sample/european-ibd-inflammatory-bowel-disease-market European IBD Inflammatory Bowel Disease Market Segmentation By Disease Type •Ulcerative Colitis •Crohn’s Disease By Diagnostics •Blood and Stool Tests •Endoscopies, •Ultrasound

  3. •X-Ray By Therapeutics • Surgery • Anti- Inflammatory Drug Administration • Steroids • Immunosuppressant • Biological Drugs • Amino salicylates • Others Regional Analysis •UK •Germany •France •Spain •Italy •Rest of Europe Company Profiles •AbbVie Inc. •Allergan, PLC •Boehringer Ingelheim International GmbH •Eli Lilly and Co. •Johnson & Johnson Services Inc. •Pfizer Inc. •Pharmacosmos A/S •Sanofi S.A. •Takeda pharmaceutical Co., Ltd. •UCB, Inc. •Vifor Pharma Group For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/european-ibd-inflammatory-bowel-disease-market About Orion Market Research

  4. Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

More Related